This is consistent with observations that ATX inhibition with BrP-LPA (also a pan-LPA receptor antagonist) or PF-8380 increased the sensitivity of heterotopic glioblastomas to RT in mice [92,93]. The gene discussed is LPA; the disease is glioblastoma.